rivastigmine has been researched along with Supranuclear Palsy, Progressive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dautzenberg, PL; Nijboer, H | 1 |
Berg, D; Di Santo, A; Gaenslen, A; Gasser, T; Godau, J; Liepelt, I; Schweitzer, KJ | 1 |
Junne, F; Krüger, R; Sammet, I; Schäffeler, N; Teufel, M; Wettach, I; Zipfel, S | 1 |
1 trial(s) available for rivastigmine and Supranuclear Palsy, Progressive
Article | Year |
---|---|
Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis.
Topics: Aged; Behavioral Symptoms; Cognition Disorders; Dementia; Female; Humans; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Supranuclear Palsy, Progressive | 2010 |
2 other study(ies) available for rivastigmine and Supranuclear Palsy, Progressive
Article | Year |
---|---|
[Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?].
Topics: Aged; Cholinesterase Inhibitors; Cognition Disorders; Deglutition Disorders; Diagnosis, Differential; Fatal Outcome; Female; Humans; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Supranuclear Palsy, Progressive; Treatment Outcome | 2009 |
[Somatoform disorder or neurological syndrome? Complex mental and movement disorder and autonomic dysfunction in a 65-year-old patient - Case 1/2011].
Topics: Adaptation, Psychological; Aged; Atrophy; Cholinesterase Inhibitors; Combined Modality Therapy; Cough; Diagnosis, Differential; Exercise Therapy; Female; Humans; Magnetic Resonance Imaging; Mesencephalon; Neurologic Examination; Occupational Therapy; Phenylcarbamates; Psychotherapy; Rivastigmine; Sick Role; Somatoform Disorders; Supranuclear Palsy, Progressive; Syncope | 2011 |